Evidence map›Paper›PMID 38944762›Full record

ArticleJAMA health forum2024

Pay-for-Performance Incentives for Home Dialysis Use and Kidney Transplant.

Kalli G Koukounas, Daeho Kim, Rachel E Patzer, Adam S Wilk, Yoojin Lee, Kelsey M Drewry, Rajnish Mehrotra, Maricruz Rivera-Hernandez, David J Meyers, Ankur D Shah and 3 more

Abstract read
In one paragraph

Article in JAMA health forum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Is Assisted Home Dialysis Feasible in the United States? Addressing Legislative and Regulatory Levers.Clinical journal of the American Society of Nephrology : CJASN · 2025
    Article
  8. Article
  9. Transforming transplantation access: A federal directive for comprehensive pre-waitlisting data collection.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kalli G KoukounasDepartment of Health Services, Policy and Practice, Brown University School of Public Health, Providence, Rhode Island.
Daeho KimDepartment of Health Services, Policy and Practice, Brown University School of Public Health, Providence, Rhode Island.
Rachel E PatzerRegenstrief Institute, Indianapolis, Indiana.
Adam S WilkDepartment of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Yoojin LeeDepartment of Health Services, Policy and Practice, Brown University School of Public Health, Providence, Rhode Island.
Kelsey M DrewryRegenstrief Institute, Indianapolis, Indiana.
Rajnish MehrotraKidney Research Institute, Division of Nephrology, Department of Medicine, University of Washington School of Medicine, Seattle.
Maricruz Rivera-HernandezDepartment of Health Services, Policy and Practice, Brown University School of Public Health, Providence, Rhode Island.
David J MeyersDepartment of Health Services, Policy and Practice, Brown University School of Public Health, Providence, Rhode Island.
Ankur D ShahWarren Alpert Medical School of Brown University, Providence, Rhode Island.
Rebecca ThorsnessPartnered Evidence-Based Policy Resource Center, VA Boston Healthcare System, Boston, Massachusetts.
Christopher H SchmidDepartment of Biostatistics, Brown University School of Public Health, Providence, Rhode Island.
Amal N TrivediDepartment of Health Services, Policy and Practice, Brown University School of Public Health, Providence, Rhode Island.

Funding

Impact of Randomized Payment Incentives on Disparities in Home Dialysis and Kidney TransplantationR01MD017080 · NIMHD · BROWN UNIVERSITY · PI Rachel E Patzer, AMAL N. TRIVEDI · 2022 to 2026
$3.2M
Effects of Expanding Medicare Advantage Enrollment toPersons with End-stage Renal DiseaseR01DK129388 · NIDDK · BROWN UNIVERSITY · PI TRIVEDI, AMAL N. · 2021 to 2024
$2.4M
Medicaid Expansion, Coverage Loss, and Disparities in Kidney Health in the COVID-19 EraR01DK113298 · NIDDK · BROWN UNIVERSITY · PI TRIVEDI, AMAL N. · 2017 to 2023
$2.2M
Infection Control Measures in Dialysis Facilities after COVID-19: Disparities in Adoption and Impact on Hospitalization and MortalityR01HS028285 · AHRQ · BROWN UNIVERSITY · PI TRIVEDI, AMAL N. · 2021 to 2022
$932k
AHRQ HHS R01 HS028285NIDDK NIH HHS R01 DK113298NIDDK NIH HHS R01 DK129388NIMHD NIH HHS R01 MD017080
6 · The paper itself

Abstract

Importance: The Centers for Medicare & Medicaid Services' mandatory End-Stage Renal Disease Treatment Choices (ETC) model, launched on January 1, 2021, randomly assigned approximately 30% of US dialysis facilities and managing clinicians to financial incentives to increase the use of home dialysis and kidney transplant. Objective: To assess the ETC's association with use of home dialysis and kidney transplant during the model's first 2 years and examine changes in these outcomes by race, ethnicity, and socioeconomic status. Design, Setting, and Participants: This retrospective cross-sectional study used claims and enrollment data for traditional Medicare beneficiaries with kidney failure from 2017 to 2022 linked to same-period transplant data from the United Network for Organ Sharing. The study data span 4 years (2017-2020) before the implementation of the ETC model on January 1, 2021, and 2 years (2021-2022) following the model's implementation. Exposure: Receiving dialysis treatment in a region randomly assigned to the ETC model. Main Outcomes and Measures: Primary outcomes were use of home dialysis and kidney transplant. A difference-in-differences (DiD) approach was used to estimate changes in outcomes among patients treated in regions randomly selected for ETC participation compared with concurrent changes among patients treated in control regions. Results: The study population included 724 406 persons with kidney failure (mean [IQR] age, 62.2 [53-72] years; 42.5% female). The proportion of patients receiving home dialysis increased from 12.1% to 14.3% in ETC regions and from 12.9% to 15.1% in control regions, yielding an adjusted DiD estimate of -0.2 percentage points (pp; 95% CI, -0.7 to 0.3 pp). Similar analysis for transplant yielded an adjusted DiD estimate of 0.02 pp (95% CI, -0.01 to 0.04 pp). When further stratified by sociodemographic measures, including age, sex, race and ethnicity, dual Medicare and Medicaid enrollment, and poverty quartile, there was not a statistically significant difference in home dialysis use across joint strata of characteristics and ETC participation. Conclusions and Relevance: In this cross-sectional study, the first 2 years of the ETC model were not associated with increased use of home dialysis or kidney transplant, nor changes in racial, ethnic, and socioeconomic disparities in these outcomes.

Indexed as

Hemodialysis, HomeKidney Failure, ChronicKidney TransplantationReimbursement, IncentiveAgedCross-Sectional StudiesFemaleHumansMaleMedicareMiddle AgedRetrospective StudiesUnited States

Identifiers

PMID38944762
PMCPMC11215557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.